IntrinsicIntrinsic
← Scroll for more →

Resmed Inc (RMD)

Surgical & Medical Instruments & Apparatus

Latest Price
$221.10
TTM P/E
21.32
Normalized P/E
29.08
Div Yield
1.09%
Book Value
44.56
P/B Ratio
4.96

Valuation metrics

adjust assumptions →
EPS: $10.43
Book value / share: $45.66
Formula: √(22.5 × EPS × BVPS)
Graham Number
$103.51
53% downside
Norm. op. income: $1.1B (median of 7yr)
Tax rate: 19%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$69.29
69% downside
Base FCF: $1.3B (median of recent 5yr)
Growth: 12%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$267.00
+21% upside
EPS: $10.43
Target P/E: 29×
Formula: EPS × P/E
P/E Fair Value
$302.47
+37% upside

Institutional Ownership

69.1% held by institutions
InstitutionSharesValueOwnership %ChangeFiling Date
BlackRock, Inc.12.32M$2.40B8.54%+223.2K2026-06-30
Vanguard Capital Management LLC9.47M$1.85B6.57%+7.7K2026-06-30
Vanguard Portfolio Management LLC7.91M$1.54B5.49%+49.7K2026-06-30
State Street Corp6.68M$1.30B4.63%+37.6K2026-06-30
Geode Capital Management, LLC4.35M$845.0M3.02%-5532026-06-30
Bank of New York Mellon Corp4.20M$818.0M2.91%-727.8K2026-06-30
First Trust Advisors LP2.28M$444.0M1.58%+740.9K2026-06-30
Invesco Ltd.2.06M$402.0M1.43%+107.0K2026-06-30
Morgan Stanley1.93M$375.0M1.34%-757.9K2026-06-30
Northern Trust Corp1.70M$330.0M1.18%-29.0K2026-06-30
View all institutional holders →